Insulin lispro in overweight type 2 diabetic patients;Insulin lispro bei übergewichtigen patienten mit diabetes mellitus typ 2

Diabetes und Stoffwechsel

Volumn 12, Issue 1, 2003, Pages 3-7

  Gudat, U ^a   Kuhn C ^b   Kazda, C ^b   Lehnert, H ^c,d  

^a Aretaeus sàrl ^*  (Switzerland)

^b LILLY DEUTSCHLAND GMBH   (Germany)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^d Klinik fur Endokrinologie   (Germany)

Author keywords

Insulin lispro; Obesity; Type 2 diabetes

Indexed keywords

ACARBOSE; GLUCOSE; HEMOGLOBIN A1C; INSULIN LISPRO; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE DURATION; DRUG TOLERABILITY; FEMALE; GALLBLADDER CARCINOMA; GANGRENE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPEN STUDY; PERITONITIS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VEIN INSUFFICIENCY; VISUAL ACUITY; WEIGHT GAIN;

EID: 0037455150     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Glazer NB, Zalani S, Anderson JH, Bastyr EJ III: Safety of Insulin Lispro: Pooled Data from Clinical Trials. Am J Health Syst Pharmacol 56 (1999) 542-547
2. Weyer C, Hanson K, Bogardus C, Prately RE: Long-term Changes in Insulin Action and Insulin Secretion Associated with Gain, Loss and Maintenance of Body Weight. Diabetologia 43 (2000) 36-46.
3. Heinemann L, Heise T, Wahl LCh, Trautmann ME, Ampudia J, Starke AAR, Berger M: Prandial Glycaemia After a Carbohydrate-rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human Insulin. Diabetic Med 13 (1996) 625-629
4. Anderson JH, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi L, and the Multicenter Insulin Lispro Study Group: Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment. Diabetes 46 (1997a) 265-270
5. Anderson JH, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R. (1997b) Mealtime Treatment with Insulin Analog Improves Postprandial Hyperglycemia and Hypoglycemia in Patients With Non-Insulin-Dependent Diabetes Mellitus. Arch Intern Med 157 (1976) 1249-1255
6. Ebeling P, Jansson PA, Smith U, Lalli C, Bolli GB, Koivisto VA: Strategies Toward Improved Control During Insulin Lispro Therapy in IDDM. Diabetes Care 20 (1997) 1287-1289
7. Lalli C, Ciofetta M, Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Cartechini MG, Bartocci L, Brunetti P, Bolli GB: Long-Term Intensive Treatment of Type 1 Diabetes with the Short-Acting Insulin Analog Lispro in Variable Combination with NPH-Insulin at Mealtime. Diabetes Care 22 (1999) 468-477
8. Valle D, Santoro D: The Italian Multicenter Study with Insulin Lispro: Final Results. Diabetes 48 (Suppl.1) (1999) 0437
9. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH, The Benelux-UK Insulin lispro Study Group: Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated with Insulin lispro. Diabetes Care 20 (1997) 1827-1832
10. Brunelle RL, Llewelyn J, Anderson JH, Gale EAM, Koivisto VA: Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type I Diabetes. Diabetes Care 21 (1998) 1726-1731
11. Holleman F, van den Brand JJG, Hoven RARA, van der Linden JM, van der Tweel I, Heokstra JBL, Erkelens DW: Comparison of LysB28, ProB29-Human Insulin Analog and Regular Human Insulin in the Correction of Incidental Hyperglycemia. Diabetes Care 19: (1996) 1426-1429
12. Stiller R, Gudat U, Pfützner A, Trautmann ME, Haslbeck M: Postprandial Treatment with Lispro Insulin. Diabet Metab 23 (1997) 232-233
13. Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA: Postprandial Insulin Lispro. Diabetes Care 21 (1998) 570-573
14. Herbold M: Nützliche Erkenntnisse über Arzneimittel im Alltag. Dt Ärztebl. 93 (1996) A3010-3012
15. Victor N, Schäfer H, Nowak H: Arzneimittelforschung nach der Zulassung. In: Medizinische Informatik und Statistik 73, (Hrsg.) K. Überla, O. Rienhoff, N. Victor. Springer Verlag, Berlin (1991)
16. Müller-Oerlingshausen B, Munter KH, Wink K: Anwendungsbeobachtungen. Dt Ärztebl 96 (1999) C527
17. Chow CC, Tsang LW, Sorenson JP, Cockram CS: Comparison of Insulin With or Without Continuation of Oral Hypoglycemic Agents in the Treatment of Secondary Failure in NIDDM Patients. Diabetes Care 18 (1995) 307-314
18. UK Prospective Study Group: Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). The Lancet 352 (1998) 837-853
19. Mäkimattila S, Nikkilä K, Yki-Järvinen H: Causes of Weight Gain during Insulin Therapy With and Without Metformin in Patients with Type II diabetes mellitus. Diabetologia 42 (1999) 406-412
20. Sinha A, Formica C, Tsalamadris C, Panagiotopoulos S, Hendrich E: Effects of Insulin on Body Composition in Patients with Insulin-dependent and Non-insulin-dependent Diabetes. Diabet Med 13 (1996) 40-46
21. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS: Intensive Conventional Insulin Therapy for Type II diabetes. Metabolic Effects During a 6-Mo Outpatient Trial. Diabetes Care 16 (1993) 21-31
22. Larger E, Rufat P, Dubois-Laforgue D, Ledoux S: Insulin Therapy does not itself Induce Weight Gain in Patients with Type 2 Diabetes. Diabetes Care 24 (2001) 1849-1850
23. Brange J, Owens DR, Kang S, Volund A: Monomeric Insulins and their Experimental and Clinical Implications. Diabetes Care 13 (1990) 923-954
24. Bruttomesso D, Pianta A, Mari A, Valerion A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S: Restoration of Early Rise in Plasma Insulin Levels Improves Glucose Tolerance of Type 2 Diabetic Patients. Diabetes 48 (1999) 99-105
25. Feinglos MN, Thacker CH, English J: Modification of Postprandial Hyperglycemia with Insulin Lispro Improves Glucose Control in Patients with Type 2 Diabetes. Diabetes Care 20 (1997) 1539-1542